HIV prevention
Nov 30, 2020 | News
ICAP at Columbia University announces two new awards from the National Institutes of Health (NIH) to support HIV prevention research in the US and globally. The first award enables the continued work of the NIH-funded HIV Prevention Trials Network (HPTN) through its...
Nov 13, 2020 | News
A landmark clinical study supported by ICAP has demonstrated that an injectable form of Pre-Exposure Prophylaxis (PrEP) is highly effective in preventing HIV acquisition in women, presenting a welcome new option to help keep women safe from the virus that causes AIDS....
Nov 11, 2020 | In the Media, News
Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was consulted for an Nov 9 article in Street Insider, Researchers from the HIV Prevention Trials Network (HPTN) announced today data from the HPTN084 clinical trial indicate that a pre-exposure prophylaxis (PrEP)...
Sep 22, 2020 | News
In its work to champion the use of Pre-Exposure Prophylaxis (PrEP) as a key strategy to protect the health of women and in the prevention of mother-to-child HIV transmission, ICAP held a learning forum to share findings on the current barriers and drivers to the use...
Sep 10, 2020 | Events, Webinars